Serotonin Expression in Lichen Planus Lesions and Its Relationship with Depression/Anxiety
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Psychological factors such as stress, depression, and anxiety have been documented to contribute to the development of lesions in lichen planus (LP). Objective: To evaluate the relationship between serotonin expression in LP lesions and depression/anxiety. Methods: Forty patients (22 females, 18 males) with LP and 20 healthy control subjects were included in this study. The severity of LP was assessed with the palmar method (using the measurement of affected body surface area [BSA]). The depression and anxiety scores were measured with Beck's depression inventory (BDI) and Beck's anxiety inventory (BAI). The expression of serotonin was determined via immunohistochemistry in LP lesions and in the control group skin using a monoclonal antibody to serotonin. Results: The skin biopsies of the LP patients had significantly higher levels of serotonin than those of the control subjects (p＜0.001). In the LP patients, and there was a positive correlation between serotonin expression and LP severity (p=0.022). Based on the results from the BDI and BAI, there was a significant relationship between the severity of depression/anxiety and intensity of serotonin expression (p ＜0.001). Conclusion: Data from this study suggest that serotonin may have a possible role in the pathogenesis of LP. Further, the relationship between serotonin expression in acute cutaneous lesions and the depression/anxiety scores indicates that serotonin may be a mediator for the association of LP and depression/anxiety simultaneously. There is a need for more specific studies showing the expression of serotonin in the lichen planus to demonstrate the cause or effect.
Abstract
Background: Psychological factors such as stress, depression, and anxiety have been documented to contribute to the development of lesions in lichen planus (LP). Objective: To evaluate the relationship between serotonin expression in LP lesions and depression/anxiety. Methods: Forty patients (22 females, 18 males) with LP and 20 healthy control subjects were included in this study. The severity of LP was assessed with the palmar method (using the measurement of affected body surface area [BSA]). The depression and anxiety scores were measured with Beck's depression inventory (BDI) and Beck's anxiety inventory (BAI). The expression of serotonin was determined via immunohistochemistry in LP lesions and in the control group skin using a monoclonal antibody to serotonin. Results: The skin biopsies of the LP patients had significantly higher levels of serotonin than those of the control subjects (p＜0.001). In the LP patients, and there was a positive correlation between serotonin expression and LP severity (p=0.022). Based on the results from the BDI and BAI, there was a significant relationship between the severity of depression/anxiety and intensity of serotonin expression (p ＜0.001). Conclusion: Data from this study suggest that serotonin may have a possible role in the pathogenesis of LP. Further, the relationship between serotonin expression in acute cutaneous lesions and the depression/anxiety scores indicates that serotonin may be a mediator for the association of LP and depression/anxiety simultaneously. There is a need for more specific studies showing the expression of serotonin in the lichen planus to demonstrate the cause or effect.
참고문헌 (35)
- Boyd AS, "Lichen planus", J Am Acad Dermatol, 25, pp.593~619 (1991)
- Lehman JS, "Lichen planus", Int J Dermatol, 48, pp.682~694 (2009)
- Marshman G, "Lichen planus", Australas J Dermatol, 39, pp.1~11 (1998)
- Shiohara T, "Dermatology" (2012), Elsevier Saunders
- Daoud MS, "Fitzpatrick's dermatology in general medicine", pp.561~577 (1999), McGraw-Hill
- Gorouhi F, "Cutaneous and mucosal lichen planus : a comprehensive review of clinical subtypes, risk factors, diagnosis, and prognosis", ScientificWorldJournal, 2014, pp.742826~ (2014)
- James WD, "Andrews' diseases of the skin: clinical dermatology" (2011), Elsevier Saunders
- Roopashree MR, "Pathogenesis of oral lichen planus--a review", J Oral Pathol Med, 39, pp.729~734 (2010)
- Öztürk MO, "Ruh Sağlığı ve Bozuklukları" (1994), Hekimler Yayın Birliği
- Tamam L, "Depresyonda serotonerjik düzenekler", Klinik Psikiyatri Dergisi, 5, pp.11~18 (2002)
- Müller N, "Immunology of major depression", Neuroimmunomodulation, 21, pp.123~130 (2014)
- Leonard BE, "The HPA and immune axes in stress: the involvement of the serotonergic system", Eur Psychiatry, (20 Suppl 3), pp.S302~S306 (2005)
- Rödström PO, "Erosive oral lichen planus and salivary cortisol", J Oral Pathol Med, 30, pp.257~263 (2001)
- Huang J, "Immunohistochemical study of serotonin in lesions of psoriasis", Int J Dermatol, 43, pp.408~411 (2004)
- Huang J, "Immunohistochemical study of serotonin in lesions of chronic eczema", Int J Dermatol, 43, pp.723~726 (2004)
- Akay A, "Assessment of depression in subjects with psoriasis vulgaris and lichen planus", J Eur Acad Dermatol Venereol, 16, pp.347~352 (2002)
- Allen CM, "Relation of stress and anxiety to oral lichen planus", Oral Surg Oral Med Oral Pathol, 61, pp.44~46 (1986)
- Bergdahl J, "Psychologic aspects of patients with oral lichenoid reactions", Acta Odontol Scand, 53, pp.236~241 (1995)
- Chaudhary S, "Psychosocial stressors in oral lichen planus", Aust Dent J, 49, pp.192~195 (2004)
- Ivanovski K, "Psychological profile in oral lichen planus", J Clin Periodontol, 32, pp.1034~1040 (2005)
- Koray M, "The evaluation of anxiety and salivary cortisol levels in patients with oral lichen planus", Oral Dis, 9, pp.298~301 (2003)
- Lundqvist EN, "Psychological health in patients with genital and oral erosive lichen planus", J Eur Acad Dermatol Venereol, 20, pp.661~666 (2006)
- Rojo-Moreno JL, "Psychologic factors and oral lichen planus. A psychometric evaluation of 100 cases", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 86, pp.687~691 (1998)
- Soto Araya M, "Association between psychological disorders and the presence of Oral lichen planus, Burning mouth syndrome and Recurrent aphthous stomatitis", Med Oral, 9, pp.1~7 (2004)
- Vallejo MJ, "Anxiety and depression as risk factors for oral lichen planus", Dermatology, 203, pp.303~307 (2001)
- El-Nour H, "Serotonergic mechanisms in human allergic contact dermatitis", Acta Derm Venereol, 87, pp.390~396 (2007)
- Lonne-Rahm SB, "Neuroimmune mechanisms in patients with atopic dermatitis during chronic stress", J Eur Acad Dermatol Venereol, 22, pp.11~18 (2008)
- Nordlind K, "Expression of serotonergic receptors in psoriatic skin", Arch Dermatol Res, 298, pp.99~106 (2006)
- Thorslund K, "The expression of serotonin transporter protein correlates with the severity of psoriasis and chronic stress", Arch Dermatol Res, 305, pp.99~104 (2013)
- Thorslund K, "The serotonin transporter protein is expressed in psoriasis, where it may play a role in regulating apoptosis", Arch Dermatol Res, 301, pp.449~457 (2009)
- Kushnir-Sukhov NM, "Human mast cells are capable of serotonin synthesis and release", J Allergy Clin Immunol, 119, pp.498~499 (2007)
- Mössner R, "Role of serotonin in the immune system and in neuroimmune interactions", Brain Behav Immun, 12, pp.249~271 (1998)
- Sperner-Unterweger B, "Immune changes and neurotransmitters : possible interactions in depression", Prog Neuropsychopharmacol Biol Psychiatry, 48, pp.268~276 (2014)
- Ahern GP, "5-HT and the immune system", Curr Opin Pharmacol, 11, pp.29~33 (2011)
- Welz-Kubiak K, "Mediators of pruritus in lichen planus", Autoimmune Dis, 2013, pp.941431~ (2013)